Elbit Imaging (EMITF) Stock Price, News & Analysis

Company Overview

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petah Tikva, Israel.

Key Stats

• Today's Range: $1.80 to $1.80
• 50-Day Range: $1.75 to $2.15
• 52-Week Range: $0.95 to $2.32
• Volume: N/A
• Average Volume: 18 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMITF Stock Analysis - Frequently Asked Questions

How have EMITF shares performed this year?

Elbit Imaging's stock was trading at $1.50 at the beginning of 2025. Since then, EMITF shares have increased by 20.0% and is now trading at $1.80.

How do I buy shares of Elbit Imaging?

Shares of EMITF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Finance
• Industry: REAL ESTATE OPS
• Sub-Industry: Real Estate
• Current Symbol: OTCMKTS:EMITF
• CIK: 1027662
• Web: www.elbitimaging.com
• Phone: (723) 608-6000
• Fax: 972-3608-6050
• Employees: 620
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.09